- Peptide Substrates
- Binding Proteins
- Secondary Antibodies
- Regulatory proteins
- 脂类激酶
- 双加氧酶与蛋白质
- 脂质底物
- E2
- Assay Buffer and Co-factors
- Methyltransferases
- Acetyltransferases
- Transcription Proteins
- COVID-19 ELISA Kits
- Tau Proteins
- Microtubule & Actin Associated Proteins
- Carbohydrate Substrates
- COVID-19 Proteins
- Chemokines
- 标记抗体
- 授予称号
- E3
- 【桥头火锅】品牌介绍→桥头火锅底料_重庆桥头火锅_买购网
- SignalChem|生产厂家|价格信息
- signalchem
- IL4 Gene GeneCards | IL4 Protein | IL4 Antibody
- 代理产品SignalchemSignalchem
- 重组人IL11说明书
- cell signaling 三天审稿完毕,小修! 论文投稿 交流 ...
- ...SignalChem一级代理,SignalChem中国代理,SignalChem公司_环保...
- “不积极”英语是什么?unactive吗?
- “不积极”英语是什么?unactive吗?
- 苏州蚂蚁淘实验试剂有限公司17年8月份销售过的产品1苏州蚂蚁淘...
- SignalChem安徽代理 |产品目录|代理商|蚂蚁淘进口试剂平行进口
Overview:
p29 ING4 is a tumor suppressor protein similar to ING1 that may inhibit tumor progression by modulating the transcriptional output of signaling pathways which regulate cell proliferation. p29 ING4 has been shown to suppress brain tumor angio-genesis through transcriptional repression of RelA/ NFKB3 target genes when complexed with RelA. p29 ING4 may also specifically suppress loss of contact inhibition elicited by activated oncogenes such as MYC. p29 ING4 shows a nuclear localization and interacts with EP300, TP53, RelA, inhibits cell growth, and induces apoptosis. This protein contains a PHD-finger, which is a common motif in proteins involved in chromatin remodeling. Multiple alternatively spliced transcript variants have been observed. The accession number listed below is for variant (1) that encodes the longest isoform.
References:
1. Shiseki,M., et al.: p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 2003: 63 (10); 2373-2378. 2. Zhang,X., et al.: ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett. 2004: 570 (1-3); 7-12. 3. Garkavtsev,I., et al.: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature. 2004: 428 (6980); 328-332.


